Simvastatin as adjuvant therapy in older patients with pneumonia and sepsis

Phase 4, randomised, double-blind trial in community-acquired pneumonia (CAP) and sepsis comparing Simvastatin plus standard of care with Placebo plus standard of care (2 arms). Primary endpoints: Change in neutrophil adhesion, chemokinesis, and chemotaxis, Change in neutrophil extracellular trap formation and 1 more. Started Nov 2012; status: completed.